Dr. Albert A. Petrossian, MD

Dr. Petrossian practices at Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System.

Dr. Petrossian's NPI, 1003136565, was assigned on June 8, 2010. Dr. Petrossian graduated from VCU School of Medicine in 2010. Dr. Petrossian holds California license A136810.

Dr. Petrossian's primary practice is Long Beach Medical Center, at 2801 Atlantic Ave, Long Beach, CA 90806 in Los Angeles County. The practice phone is (562) 933-2000.

Dr. Petrossian's primary practice is Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System. Dr. Petrossian is also affiliated with Dignity Health - St. Mary Medical Center. The medical group on file is Ascent Urology. Dmand AI also links Dr. Petrossian to 3 more hospitals, 1 physician office, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Petrossian practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Petrossian's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Petrossian is board certified in urology by the American Board of Urology. Dmand AI has Dr. Petrossian's licenses on file in 2 states: California and Virginia.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Petrossian treats.

CMS data shows 10,148 Medicare services from Dr. Petrossian across 39 procedure codes in 2024, for 753 Medicare patients. Medicare paid $498,889 for them.

CMS counts 753 Medicare patients who saw Dr. Petrossian in 2024. The largest group is 75 to 84, with 307 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Petrossian's median patient age at 72, with 31% women.

In 2024, Dr. Petrossian wrote 2,275 Medicare Part D claims for 439 patients. 86% of them were for generic drugs. CMS names the drug for 2,102 of them, across 28 drugs with 11 or more claims each, at $647,060 in total drug cost. In 2023, CMS named 1,818 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Petrossian for performance year 2024, reported individually. CMS lists Dr. Petrossian as offering telehealth. CMS counts 31 procedures of prostate resection by Dr. Petrossian, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Petrossian, published from 2013 to 2018. 2014 was the busiest year, with 2. The most frequent topics are Cell Line, Tumor, Cystoscopy and Immunomodulation. Dr. Petrossian's most frequent co-authors are Joseph Reza Habibi, MD, Adam P. Klausner, MD and David E. Rapp, MD.

Dmand AI links Dr. Petrossian to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 268 general payments to Dr. Petrossian from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Astellas Pharma US Inc paid the most, $1,790.

Dr. Petrossian graduated from VCU School of Medicine in 2010.

Dr. Petrossian is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.